Siren Biotechnology

Siren Bio

This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.

Mnemo Therapeutics

This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.

NanoCell Therapeutics, Inc.

The company develops non-viral, DNA-based in-vivo gene therapy platforms to treat oncology and autoimmune diseases for patients and healthcare providers.

Salve Therapeutics

The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Gene Therapy Delivery Methods

This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.

Kodikaz Therapeutics

Kodikaz Therapeutics develops a cell-specific non-viral delivery platform for targeted gene therapies to treat various cancers for patients and healthcare providers.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.